Leukotrap - AS-3
Additive Solution Formula 3
Approved
Approval ID
e15674bf-142b-653c-e053-2995a90a726a
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Jun 13, 2022
Manufacturers
FDA
Haemonetics Corporation
DUNS: 057827420
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
AS-3
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code53157-460
Application NumberBN820915
Product Classification
M
Marketing Category
C73594
G
Generic Name
AS-3
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateJune 13, 2022
FDA Product Classification
INGREDIENTS (7)
SODIUM CITRATEInactive
Code: 1Q73Q2JULR
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT
DEXTROSE, UNSPECIFIED FORMActive
Quantity: 1 g in 100 mL
Code: IY9XDZ35W2
Classification: ACTIB
ADENINEActive
Quantity: 0.03 g in 100 mL
Code: JAC85A2161
Classification: ACTIB
CITRIC ACID MONOHYDRATEInactive
Code: 2968PHW8QP
Classification: IACT
SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATEInactive
Code: 593YOG76RN
Classification: IACT
SODIUM CHLORIDEInactive
Code: 451W47IQ8X
Classification: IACT